1. AB0255 The Association between Rheumatoid Factor Positivity and Effects of Treatment with A First Biologic Agent in Rheumatoid Arthritis. (15th July 2016) Authors: Ogawa, Y.; Kojima, T.; Takahashi, N.; Funahashi, K.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0314 Setting treatment target for joint surgery in lower limbs in patients with long-standing rheumatoid arthritis based on multicenter prospective cohort study; validation and reliability of objective index of activity speed, timed up and go test, for measuring physical function. (12th June 2018) Authors: Kojima, T.; Ishikawa, H.; Tanaka, S.; Haga, N.; Nishida, K.; Yukioka, M.; Hashimoto, J.; Miyahara, H.; Niki, Y.; Kimura, T.; Oda, H.; Funahashi, K.; Asai, S.; Kojima, M.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0336 Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving tocilizumab treatment comparison with infliximab treatment from japanese tbcr. (23rd January 2014) Authors: Kanayama, Y.; Kojima, T.; Hirano, Y.; Yabe, Y.; Takahashi, N.; Funahashi, K.; Oishi, Y.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0338 Improving of safety of treatment for the elderly patients with rheumatoid arthritis using biologics; results from over 2 years surveillance using multicenter registry in japan. (23rd January 2014) Authors: Kojima, T.; Funahashi, K.; Takahashi, N.; Kato, D.; Matsubara, H.; Hattori, Y.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0368 Epidemiology and therapeutic option of bacterial pneumonia in RA patients treated with biologics from multi-center registry in japan. (23rd January 2014) Authors: Kato, D.; Kojima, T.; Takahashi, N.; Funahashi, K.; Matsubara, H.; Hattori, Y.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0377 Differences in Baseline Predictive Factors for Remission at 52 Weeks by Concomitant MTX Use during Tocilizumab Treatment Using Propensity Score Matched Groups. (15th July 2016) Authors: Kojima, T.; Asai, S.; Takahashi, N.; Yabe, Y.; Hirano, Y.; Kanayama, Y.; Kaneko, A.; Takemoto, T.; Asai, N.; Watanabe, T.; Funahashi, K.; Hayashi, M.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0404 Concomitant Methotrexate Did not Affect Discontinuation Rate of Etanercept Due to Ineffectiveness: Six-Year Results from Japanese Multicenter Registry System. (10th June 2014) Authors: Takahashi, N.; Kojima, T.; Funahashi, K.; Hanabayashi, M.; Hirabara, S.; Asai, S.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0442 Twelve Weeks is Long Enough to PREDICT Low Disease Activity at 52 Weeks in Rheumatoid Arthritis Patients Treated with Abatacept. (10th June 2014) Authors: Takahashi, N.; Kojima, T.; Funahashi, K.; Hanabayashi, M.; Hirabara, S.; Asai, S.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0466 The Outcome of Tocilizumab Treatment with Achievement of Glucocorticoids Withdrawal Against Rheumatoid Arthritis for 24 Months from TBC Registry. (9th June 2015) Authors: Funahashi, K.; Kojima, T.; Takahashi, N.; Asai, S.; Yoshioka, Y.; Takemoto, T.; Terabe, K.; Asai, N.; Yabe, Y.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0476 Influence of the Reason for Discontinuation of Previous TNF Antagonists on the Retention of Tocilizumab. (9th June 2015) Authors: Asai, N.; Yabe, Y.; Kojima, T.; Takahashi, N.; Funahashi, K.; Asai, S.; Takemoto, T.; Terabe, K.; Yoshioka, Y.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗